Eslicarbazepine Acetate Tablets are indicated for the treatment of partial-onset seizures in patients 4 years of age and older.
PISCTWAY, N.J. – Camber Pharmaceuticals announces the addition of Eslicarbazepine Acetate Tablets to its portfolio.
Eslicarbazepine Acetate Tablets are indicated for the treatment of partial-onset seizures in patients 4 years of age and older.
Eslicarbazepine Acetate Tablets are available in:
To find out more information on Eslicarbazepine Acetate Tablets, visit: www.camberpharma.com/eslicarbazepine
The meeting will feature perspectives linking leadership, innovation, and history during a pivotal time for the country and pharmacy industry.
Historic PBM reforms enacted last week mark a major milestone — and swift implementation and additional reforms remain essential.
Backed by EmpiRx Health’s frontline pharmacists and AI-powered technologies, “MO” optimizes the patients’ drug mix to improve member health outcomes and lower costs.
During remarks delivered at last month’s FMI Midwinter Executive Conference, Boyan, who is also the association’s chairman, spoke about what motivates the company.
In an AI-mediated marketplace, Sebok suggested, that distinction may be the difference between relevance and invisibility.
David Pinto looks ahead to the significance of the NACDS Annual Meeting in April.
New research from the Kearney Consumer Institute uncovers some hidden aspects of the trend, which, of course, has serious implications for both mass market retailers and consumer packaged goods companies.
